Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
2020 · New England Journal of Medicine · 2,821 citations
https://doi.org/10.1056/nejmoa2017699
L
Lars Henrik Jensen
Vejle Sygehus(DK)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
291
Papers
7.9K
Citations
33
h-index
83
i10-index
Lars Henrik Jensen is an academic researcher from Vejle Sygehus. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Genetic factors in colorectal cancer & Cancer Genomics and Diagnostics. The author has an h-index of 33, co-authored 248 publications.
ORCID: 0000-0002-0020-1537Papers by this author
worksPembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
2022 · The Lancet Oncology · 842 citations
https://doi.org/10.1016/s1470-2045(22)00197-8
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
2025 · The Lancet · 130 citations
https://doi.org/10.1016/s0140-6736(24)02848-4
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study
2024 · Annals of Oncology · 75 citations
https://doi.org/10.1016/j.annonc.2024.11.012
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
2024 · Journal of Clinical Oncology · 70 citations
https://doi.org/10.1200/jco.23.02736
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
2022 · ESMO Open · 69 citations
https://doi.org/10.1016/j.esmoop.2022.100529
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat